valilxoybate (XW10172)
Narcolepsy and Non-motor Symptoms of Parkinson's disease (sleep disorders)
Phase 2Active
Key Facts
Indication
Narcolepsy and Non-motor Symptoms of Parkinson's disease (sleep disorders)
Phase
Phase 2
Status
Active
Company
About XWPharma
Clinical-stage CNS biotech developing novel small molecules for narcolepsy, Parkinson's disease sleep disorders, depression, and chronic pain using time-regulated neurobiology.
View full company profile